Israeli Teva Pharmaceutical completes acquisition of oncology drugs factory in Bucharest
Israeli drugs giant Teva Pharmaceutical completed its USD 40 billion acquisition of the generics arm of rival Allergan, according to an official statement, timesofisrael.com informs, the deal including also Actavis-Sindan Pharma oncology…